BioPower Operations Corp. (BOPO) Financials Nov 14
Post# of 250675
Posted On: 11/17/2014 4:16:57 AM
BioPower Operations Corp. (BOPO) Financials Nov 14, 2014, 8:10 p.m.
Income Statement Balance Sheet Cash Flow Statement
Annual Financials for BioPower Operations Corp.
Fiscal year is December-November. All values USD millions. 2010 2011 2012 2013 5-year trend
Sales/Revenue - 0 0 0 0
Cost of Goods Sold (COGS) incl. D&A - 0 0 10,552 5,552
COGS excluding D&A - 0 0 0 0
Depreciation & Amortization Expense - 0 0 10,552 5,552
Depreciation - 0 0 5,552 5,552
Amortization of Intangibles - 0 0 5,000 0
Gross Income - 0 0 (10,552) (5,552)
2010 2011 2012 2013 5-year trend
SG&A Expense - 1,334 964,605 974,318 1.3M
Research & Development - 0 0 0 -
Other SG&A - 1,334 964,605 974,318 1.3M
Other Operating Expense - 0 0 0 0
Unusual Expense - 0 0 107,295 266,971
EBIT after Unusual Expense - 0 0 (107,295) (266,971)
Non Operating Income/Expense - 0 0 (55,069) 258,734
Non-Operating Interest Income - - 0 0 0
Equity in Affiliates (Pretax) - 0 0 - 0
Interest Expense - 0 4,050 127,214 32,893
Gross Interest Expense - 0 4,050 127,214 32,893
Interest Capitalized - 0 0 0 0
Pretax Income - (1,334) (968,655) (1.27M) (1.34M)
Income Tax - 0 0 0 0
Income Tax - Current Domestic - 0 0 - -
Income Tax - Current Foreign - 0 0 - -
Income Tax - Deferred Domestic - 0 0 - -
Income Tax - Deferred Foreign - 0 0 - -
Income Tax Credits - 0 0 - -
Equity in Affiliates - 0 0 0 0
Other After Tax Income (Expense) - - - 0 0
Consolidated Net Income - (1,334) (968,655) (1.27M) (1.34M)
Minority Interest Expense - 0 0 0 0
Net Income - (1,334) (968,655) (1.27M) (1.34M)
Extraordinaries & Discontinued Operations - 0 0 0 0
Extra Items & Gain/Loss Sale Of Assets - 0 0 0 0
Cumulative Effect - Accounting Chg - 0 0 0 0
Discontinued Operations - 0 0 0 0
Net Income After Extraordinaries - (1,334) (968,655) (1.27M) (1.34M)
Preferred Dividends - 0 0 0 0
Net Income Available to Common - (1,334) (968,655) (1.27M) (1.34M)
EPS (Basic) - (0.65) (0.05) (0.05) (0.06)
Basic Shares Outstanding - 2,000 15.63M 18.06M 23.53M
EPS (Diluted) - (0.65) (0.05) (0.05) (0.06)
Diluted Shares Outstanding - 2,000 15.63M 18.06M 23.53M
EBITDA - (1,334) (964,605) (974,318) (1.3M)
Copyright 2014 FactSet Research Systems Inc. All rights reserved. Source FactSet Fundamentals.
Income Statement Balance Sheet Cash Flow Statement
Annual Financials for BioPower Operations Corp.
Fiscal year is December-November. All values USD millions. 2010 2011 2012 2013 5-year trend
Sales/Revenue - 0 0 0 0
Cost of Goods Sold (COGS) incl. D&A - 0 0 10,552 5,552
COGS excluding D&A - 0 0 0 0
Depreciation & Amortization Expense - 0 0 10,552 5,552
Depreciation - 0 0 5,552 5,552
Amortization of Intangibles - 0 0 5,000 0
Gross Income - 0 0 (10,552) (5,552)
2010 2011 2012 2013 5-year trend
SG&A Expense - 1,334 964,605 974,318 1.3M
Research & Development - 0 0 0 -
Other SG&A - 1,334 964,605 974,318 1.3M
Other Operating Expense - 0 0 0 0
Unusual Expense - 0 0 107,295 266,971
EBIT after Unusual Expense - 0 0 (107,295) (266,971)
Non Operating Income/Expense - 0 0 (55,069) 258,734
Non-Operating Interest Income - - 0 0 0
Equity in Affiliates (Pretax) - 0 0 - 0
Interest Expense - 0 4,050 127,214 32,893
Gross Interest Expense - 0 4,050 127,214 32,893
Interest Capitalized - 0 0 0 0
Pretax Income - (1,334) (968,655) (1.27M) (1.34M)
Income Tax - 0 0 0 0
Income Tax - Current Domestic - 0 0 - -
Income Tax - Current Foreign - 0 0 - -
Income Tax - Deferred Domestic - 0 0 - -
Income Tax - Deferred Foreign - 0 0 - -
Income Tax Credits - 0 0 - -
Equity in Affiliates - 0 0 0 0
Other After Tax Income (Expense) - - - 0 0
Consolidated Net Income - (1,334) (968,655) (1.27M) (1.34M)
Minority Interest Expense - 0 0 0 0
Net Income - (1,334) (968,655) (1.27M) (1.34M)
Extraordinaries & Discontinued Operations - 0 0 0 0
Extra Items & Gain/Loss Sale Of Assets - 0 0 0 0
Cumulative Effect - Accounting Chg - 0 0 0 0
Discontinued Operations - 0 0 0 0
Net Income After Extraordinaries - (1,334) (968,655) (1.27M) (1.34M)
Preferred Dividends - 0 0 0 0
Net Income Available to Common - (1,334) (968,655) (1.27M) (1.34M)
EPS (Basic) - (0.65) (0.05) (0.05) (0.06)
Basic Shares Outstanding - 2,000 15.63M 18.06M 23.53M
EPS (Diluted) - (0.65) (0.05) (0.05) (0.06)
Diluted Shares Outstanding - 2,000 15.63M 18.06M 23.53M
EBITDA - (1,334) (964,605) (974,318) (1.3M)
Copyright 2014 FactSet Research Systems Inc. All rights reserved. Source FactSet Fundamentals.
(0)
(0)